RELATIONSHIP BETWEEN C-ERBB-2 IMMUNOREACTIVITY AND THYMIDINE LABELING INDEX IN BREAST-CARCINOMA INSITU

被引:48
作者
BARNES, DM
MEYER, JS
GONZALEZ, JG
GULLICK, WJ
MILLIS, RR
机构
[1] ST LUKES HOSP,CHESTERFIELD,MO
[2] JEWISH HOSP ST LOUIS,ST LOUIS,MO 63110
[3] WASHINGTON UNIV,SCH MED,ST LOUIS,MO 63110
[4] HAMMERSMITH HOSP,IMPERIAL CANC RES FUND,MOLEC ONCOL GRP,LONDON W12 0HS,ENGLAND
关键词
C-ERBB-2; IMMUNOHISTOCHEMISTRY; THYMIDINE LABELING INDEX; BREAST CARCINOMA INSITU;
D O I
10.1007/BF01975438
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The relationship between the presence of the c-erbB-2 protein, demonstrated immunohistochemically with antibody 21N, and thymidine labelling index (TLI) has been studied in the in situ component of 70 cases of carcinoma of the breast. A significant association was found between high TLI and positive staining. Twenty of the 70 cases stained (29%) and of those that were stained 75% had a high TLI; 43% of those with a high TLI stained positively but only 14% of those with a low TLI stained positively. Strong correlations were seen between nuclear size and histological pattern and both 21N staining and TLI. The majority of carcinomas of comedo pattern with large nuclei were 21N positive and had a high TLI, whilst those with small nuclei and a predominantly cribriform/micropapillary appearance did not stain and had a low TLI. In tumours of mixed histological pattern there was less concordance between staining and TLI. The significance of these findings in relation to the biological behaviour of these tumours and their clinical management is discussed.
引用
收藏
页码:11 / 17
页数:7
相关论文
共 24 条
  • [1] AN IMMUNOHISTOCHEMICAL EVALUATION OF C-ERB-2 EXPRESSION IN HUMAN-BREAST CARCINOMA
    BARNES, DM
    LAMMIE, GA
    MILLIS, RR
    GULLICK, WL
    ALLEN, DS
    ALTMAN, DG
    [J]. BRITISH JOURNAL OF CANCER, 1988, 58 (04) : 448 - 452
  • [2] BREAST-CANCER AND A PROTO-ONCOGENE
    BARNES, DM
    [J]. BRITISH MEDICAL JOURNAL, 1989, 299 (6707) : 1061 - 1062
  • [3] IMMUNOHISTOCHEMICAL DEMONSTRATION OF C-ERBB-2-PROTEIN IN MAMMARY DUCTAL CARCINOMA INSITU
    BARTKOVA, J
    BARNES, DM
    MILLIS, RR
    GULLICK, WJ
    [J]. HUMAN PATHOLOGY, 1990, 21 (11) : 1164 - 1167
  • [4] PREDICTION OF RELAPSE OR SURVIVAL IN PATIENTS WITH NODE-NEGATIVE BREAST-CANCER BY DNA FLOW-CYTOMETRY
    CLARK, GM
    DRESSLER, LG
    OWENS, MA
    POUNDS, G
    OLDAKER, T
    MCGUIRE, WL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (10) : 627 - 633
  • [5] EXPRESSION OF THE C-ERBB-2 PROTEIN IN NORMAL AND TRANSFORMED-CELLS
    GULLICK, WJ
    BERGER, MS
    BENNETT, PLP
    ROTHBARD, JB
    WATERFIELD, MD
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1987, 40 (02) : 246 - 254
  • [6] C-ERBB-2 EXPRESSION IN BENIGN AND MALIGNANT BREAST DISEASE
    GUSTERSON, BA
    MACHIN, LG
    GULLICK, WJ
    GIBBS, NM
    POWLES, TJ
    ELLIOTT, C
    ASHLEY, S
    MONAGHAN, P
    HARRISON, S
    [J]. BRITISH JOURNAL OF CANCER, 1988, 58 (04) : 453 - 457
  • [7] HEINTZ NH, 1990, ARCH PATHOL LAB MED, V114, P160
  • [8] INSITU DISTRIBUTION OF ONCOGENE PRODUCTS AND GROWTH-FACTOR RECEPTORS IN BREAST-CARCINOMA - C-ERBB-2 ONCOPROTEIN, EGFR, AND PDGFR-BETA-SUBUNIT
    KOMMOSS, F
    COLLEY, M
    HART, CE
    FRANKLIN, WA
    [J]. MOLECULAR AND CELLULAR PROBES, 1990, 4 (01) : 11 - 23
  • [9] AN IMMUNOHISTOCHEMICAL STUDY OF THE PRESENCE OF C-ERBB-2 PROTEIN IN PAGETS-DISEASE OF THE NIPPLE
    LAMMIE, GA
    BARNES, DM
    MILLIS, RR
    GULLICK, WJ
    [J]. HISTOPATHOLOGY, 1989, 15 (05) : 505 - 514
  • [10] PROLIFERATIVE INDEX OF BREAST-CARCINOMA BY THYMIDINE LABELING - PROGNOSTIC POWER INDEPENDENT OF STAGE, ESTROGEN AND PROGESTERONE RECEPTORS
    MEYER, JS
    PROVINCE, M
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1988, 12 (02) : 191 - 204